The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase IB study of pembrolizumab in combination with chemoradiotherapy (CRT) for locally-advanced squamous cell carcinoma of the head and neck (LA-SCCHN).
 
Steven Francis Powell
Research Funding - Merck Sharp & Dohme (Inst)
 
Mark Mutuota Gitau
Research Funding - Merck (Inst)
 
William Charles Spanos
Honoraria - Acell/MatriStem
Travel, Accommodations, Expenses - Stryker
 
Ashley Wayne Jensen
No Relationships to Disclose
 
Ryan Kenneth Nowak
No Relationships to Disclose
 
Michele Lohr
No Relationships to Disclose
 
Susan E Puumala
No Relationships to Disclose
 
Christie Ellison
No Relationships to Disclose
 
Lora Jane Black
No Relationships to Disclose
 
Jonathan D. Cheng
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Assuntina Gesualda Sacco
Consulting or Advisory Role - Pfizer
Research Funding - VentiRx (Inst)
 
Ezra E.W. Cohen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Merck; Novartis
Speakers' Bureau - Bayer; Eisai
 
John H. Lee
No Relationships to Disclose